Ventura Capital Privado
Ventura Capital Privado is a venture capital firm in Mexico City, Mexico, investing at Series A, Series B and Series C. Its latest deals were Owlstone Medical, Ltd. (Series E, Jan 2025), Plum Fintech Limited (Series B, May 2024) and Railsbank Technology Limited (Series C, Oct 2022).
Is your startup a good fit for Ventura Capital Privado?
About Ventura Capital Privado
Ventura Capital Privado is a private equity firm that focuses on companies based in Mexico. The firm invests in consumer goods and services, healthcare, telecommunications, real estate, financial services and entertainment.
- Type
- Venture Capital Firm
- Headquarters
- Mexico City, Ciudad de Mexico, Mexico
- Stages
- Series ASeries BSeries CSeries DSeries ESeries F
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- —4
- Series E2
- Growth Capital/Expansion1
- Series A1
- Series B1
Across 13 deals
Portfolio sectors
- Financial Services2
- Software2
- Food1
- Internet1
- Medical Devices & Equipment1
Across 8 companies
Portfolio countries
- UK3
- Mexico2
- US2
- Spain1
Across 8 companies
Recent investments
Newest 5 of 13
- Series E$27M
Owlstone Medical, Ltd.
Jan 2025 · Series E
- Series B$16.2M
Plum Fintech Limited
May 2024 · Series B
- Series C$25.4M
Railsbank Technology Limited
Oct 2022 · Series C
- Series A$14.5M
Plum Fintech Limited
Oct 2021 · Series A
- Series E$105.1M
Upgrade Inc.
Jul 2021 · Series E
Offices
1 location
- Mexico City, Ciudad de Mexico, MexicoHQ
Questions about Ventura Capital Privado
What type of firm is Ventura Capital Privado?
Ventura Capital Privado is a venture capital firm, founded in 2013.
Is Ventura Capital Privado actively investing?
Ventura Capital Privado has no investments on record in the last 12 months. Its last recorded deal was Owlstone Medical, Ltd. in Jan 2025.
What stages does Ventura Capital Privado invest in?
Ventura Capital Privado has invested at Series A, Series B, Series C, Series D, Series E and Series F. Its most frequent rounds on record are —, Series E and Growth Capital/Expansion.